Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: The cross talk between type II diabetic microenvironment and the regenerative capacities of human adipose tissue-derived pericytes: a promising cell therapy

Fig. 3

Assessment of cytotoxicity and the level of intracellular ROS for NS-PCs or DS-PCs at days 6, 14, and 30. A Flow cytometry analysis for apoptosis. The dot plot shows the following populations: necrotic (Q1-upper left), late apoptosis (Q2-upper right), early apoptosis (Q3-lower right), and viable cells (Q4-lower left). B, C Quantitative analysis of the apoptosis rate for NS-PCs or DS-PCs at days 6, 14, and 30. The data are presented as the mean ± standard deviation (*p < 0.05, ***p < 0.0001). D Intracellular ROS measurement assay for NS-PCs or DS-PCs at days 6, 14, and 30. The data are presented as the mean ± standard deviation

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512